Background Image
Previous Page  88 / 232 Next Page
Information
Show Menu
Previous Page 88 / 232 Next Page
Page Background

Kumpulan Fima Berhad

(11817-V)

86

Details of the remuneration of the Directors of the Company for the financial year ended 31 March 2017 are as follows:

The aggregate remuneration are as follows:

Executive

Director

Non-Executive Directors

Dato’ Roslan

bin Hamir

Tan Sri Dato’ Ir.

Muhammad Radzi

bin Haji Mansor

Azizan bin

Mohd Noor

Rozana Zeti

binti Basir

Dato’

Rosman

bin Abdullah

Rozilawati

binti

Haji Basir

RM

Company

Fees

-

90,000

75,000

67,500

67,500 60,000

Meeting

Allowance

-

18,000

30,000

28,000

34,000 22,000

Salaries

439,944

-

-

-

-

-

Bonus

245,091

-

-

-

-

-

Benefits-in-kind

343,380

-

28,584

-

37,102 19,960

Others

130,963

-

-

-

-

-

Total

1,159,378

108,000

133,584

95,500 138,602 101,960

Subsidiaries

Fees

-

16,412

12,000

-

-

-

Meeting

Allowance

-

3,000

4,000

-

-

-

Salaries

659,904

-

-

-

-

-

Bonus

367,639

-

-

-

-

-

Benefits-in-kind

54,230

-

-

-

-

-

Others

196,829

-

-

-

-

-

Total

1,278,602

19,412

16,000

-

-

-

The number of Directors whose total remuneration falls within the respective bands is tabulated as follows:

Bands

Number of Directors (Company)

Executive

Non-Executive

RM2,400,001 – RM2,450,000

1

-

RM100,001 – RM150,000

-

2

RM50,001 – RM100,000

-

3

The Directors’ fees were last increased in FYE2014. The Directors’ fees for FY2018 will remain unchanged at RM360,000

per annum. Shareholders’ approval will be sought accordingly at the forthcoming 45

th

AGM.

The Group MD is not entitled to Director’s fees nor is he entitled to receive any meeting allowance for Board and

Board Committee meetings that he attends. The Group MD’s remuneration package comprises a fixed component which

includes monthly salary and benefits-in-kind/emoluments such as medical, company car, driver and leave passage; and

a variable component which includes short-term incentives in the form of a performance-based bonus and long-term

incentives in the forms of shares under the Group’s Employees’ Share Scheme (“ESS”) comprises of Restricted Share

Grant Scheme and Options Share. The Group’s ESS expired on 17 November 2016.

statement on

corporate governance